BTEE.L vs. BTEC.L
BTEE.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) and BTEC.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) are both Health & Biotech Equities funds from iShares - BTEE.L tracks the NASDAQ Biotechnology TR USD while BTEC.L tracks the NASDAQ Biotechnology NET Index. Both are passively managed. Over the past 5 years, BTEE.L returned 5.78%/yr vs 5.87%/yr for BTEC.L. With a 0.98 correlation, they move nearly in lockstep. Both charge a 0.35% expense ratio.
Performance
BTEE.L vs. BTEC.L - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with BTEE.L having a 14.55% return and BTEC.L slightly higher at 15.22%.
BTEE.L
- 1D
- 0.32%
- 1M
- 8.88%
- 6M
- 12.51%
- YTD
- 14.55%
- 1Y
- 49.20%
- 3Y*
- 17.34%
- 5Y*
- 5.78%
- 10Y*
- —
BTEC.L
- 1D
- 0.68%
- 1M
- 9.55%
- 6M
- 13.18%
- YTD
- 15.22%
- 1Y
- 50.31%
- 3Y*
- 16.99%
- 5Y*
- 5.87%
- 10Y*
- —
BTEE.L vs. BTEC.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 14.55% | 32.76% | -1.61% | 5.72% | -11.87% | -0.47% | 27.48% | 25.64% | -13.61% |
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | 15.22% | 32.96% | -2.04% | 6.22% | -11.92% | -0.49% | 27.40% | 25.57% | -11.31% |
Correlation
The correlation between BTEE.L and BTEC.L is 0.99 - these two move nearly in lockstep. At this level, holding both provides almost no diversification benefit. If you already own one, adding the other does little to reduce portfolio risk.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.99 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.99 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.99 |
Correlation (All Time) Calculated using the full available price history since Mar 5, 2018 | 0.98 |
The correlation between BTEE.L and BTEC.L has been stable across timeframes, ranging from 0.98 to 0.99 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BTEE.L vs. BTEC.L — Risk / Return Rank
BTEE.L
BTEC.L
BTEE.L vs. BTEC.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BTEE.L | BTEC.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | 0.00 | ||
| Sortino ratioReturn per unit of downside risk | -0.02 | ||
| Omega ratioGain probability vs. loss probability | 1.39 | 1.39 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 6.41 | 6.22 | +0.19 |
| Martin ratioReturn relative to average drawdown | 19.12 | 19.15 | -0.03 |
Loading charts...
Drawdowns
BTEE.L vs. BTEC.L - Drawdown Comparison
The maximum BTEE.L drawdown since its inception was -38.29%, roughly equal to the maximum BTEC.L drawdown of -38.42%. Use the drawdown chart below to compare losses from any high point for BTEE.L and BTEC.L.
Loading charts...
Drawdown Indicators
| BTEE.L | BTEC.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.29% | -38.42% | +0.13% |
Max Drawdown (1Y)Largest decline over 1 year | -7.64% | -7.94% | +0.30% |
Max Drawdown (3Y)Largest decline over 3 years | -26.76% | -26.74% | -0.02% |
Max Drawdown (5Y)Largest decline over 5 years | -38.29% | -38.42% | +0.13% |
Current DrawdownCurrent decline from peak | -4.35% | -3.87% | -0.48% |
Average DrawdownAverage peak-to-trough decline | -13.35% | -13.22% | -0.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.57% | 2.58% | -0.01% |
Volatility
BTEE.L vs. BTEC.L - Volatility Comparison
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) has a higher volatility of 6.46% compared to iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) (BTEC.L) at 5.91%. This indicates that BTEE.L's price experiences larger fluctuations and is considered to be riskier than BTEC.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BTEE.L | BTEC.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.46% | 5.91% | +0.55% |
Volatility (6M)Calculated over the trailing 6-month period | 15.52% | 15.67% | -0.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.37% | 20.42% | -0.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.20% | 21.39% | -0.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.48% | 22.37% | +0.11% |
BTEE.L vs. BTEC.L - Expense Ratio Comparison
Both BTEE.L and BTEC.L have an expense ratio of 0.35%.
Dividends
BTEE.L vs. BTEC.L - Dividend Comparison
BTEE.L's dividend yield for the trailing twelve months is around 0.23%, while BTEC.L has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.23% | 0.37% | 0.46% | 0.39% | 0.44% | 0.25% | 0.17% | 0.14% | 0.07% |
Frequently Asked Questions
With a correlation of 0.99, BTEE.L and BTEC.L move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.
Both ETFs have the same 0.35% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
BTEE.L and BTEC.L have the same expense ratio: 0.35% per year.
BTEE.L tracks NASDAQ Biotechnology TR USD, while BTEC.L tracks NASDAQ Biotechnology NET Index.
Find the right allocation for BTEE.L and BTEC.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer